WPI 2227 (Flutamide 125 mg)
Pill with imprint WPI 2227 is Brown & White, Capsule-shape and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc..
Flutamide is used in the treatment of hirsutism; prostate cancer and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2227
Flutamide
- Imprint:
- WPI 2227
- Strength:
- 125 mg
- Color:
- Brown & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiandrogens
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00591-2466
More about flutamide
- Flutamide Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- Drug class: antiandrogens
Consumer resources
Other brands: Eulexin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
